Atypical antipsychotics in bipolar and schizoaffective disorders

E. S. Brown, N. R. Thomas, T. Carmody, S. Mahadi, V. A. Nejtek

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

No data are available comparing the relative efficacy of different atypical agents in patients with bipolar disorder. A chart review of bipolar and schizoaffective disorder patients who had received courses of at least two atypical agents (n = 33) in a community psychiatry system was conducted. No differences in rates of hospitalizations were found between individual atypical agents or between atypical agents as a class and conventional neuroleptics. However, a significant reduction in rates of emergency room visits was found with atypical agents compared to conventional neuroleptics, with a trend toward greater reduction with clozapine compared to other atypical antipsychotics. Larger prospective studies are needed to confirm these preliminary observations.

Original languageEnglish (US)
Pages (from-to)80-81
Number of pages2
JournalPharmacopsychiatry
Volume34
Issue number2
DOIs
StatePublished - 2001

Fingerprint

Bipolar Disorder
Psychotic Disorders
Antipsychotic Agents
Community Psychiatry
Clozapine
Proxy
Hospital Emergency Service
Hospitalization
Prospective Studies

ASJC Scopus subject areas

  • Pharmacology (medical)
  • Psychiatry and Mental health
  • Pharmacology, Toxicology and Pharmaceutics(all)

Cite this

Atypical antipsychotics in bipolar and schizoaffective disorders. / Brown, E. S.; Thomas, N. R.; Carmody, T.; Mahadi, S.; Nejtek, V. A.

In: Pharmacopsychiatry, Vol. 34, No. 2, 2001, p. 80-81.

Research output: Contribution to journalArticle

Brown, E. S. ; Thomas, N. R. ; Carmody, T. ; Mahadi, S. ; Nejtek, V. A. / Atypical antipsychotics in bipolar and schizoaffective disorders. In: Pharmacopsychiatry. 2001 ; Vol. 34, No. 2. pp. 80-81.
@article{4b42f443d7134da29e68f9686a831174,
title = "Atypical antipsychotics in bipolar and schizoaffective disorders",
abstract = "No data are available comparing the relative efficacy of different atypical agents in patients with bipolar disorder. A chart review of bipolar and schizoaffective disorder patients who had received courses of at least two atypical agents (n = 33) in a community psychiatry system was conducted. No differences in rates of hospitalizations were found between individual atypical agents or between atypical agents as a class and conventional neuroleptics. However, a significant reduction in rates of emergency room visits was found with atypical agents compared to conventional neuroleptics, with a trend toward greater reduction with clozapine compared to other atypical antipsychotics. Larger prospective studies are needed to confirm these preliminary observations.",
author = "Brown, {E. S.} and Thomas, {N. R.} and T. Carmody and S. Mahadi and Nejtek, {V. A.}",
year = "2001",
doi = "10.1055/s-2001-15179",
language = "English (US)",
volume = "34",
pages = "80--81",
journal = "Pharmacopsychiatry",
issn = "0176-3679",
publisher = "Georg Thieme Verlag",
number = "2",

}

TY - JOUR

T1 - Atypical antipsychotics in bipolar and schizoaffective disorders

AU - Brown, E. S.

AU - Thomas, N. R.

AU - Carmody, T.

AU - Mahadi, S.

AU - Nejtek, V. A.

PY - 2001

Y1 - 2001

N2 - No data are available comparing the relative efficacy of different atypical agents in patients with bipolar disorder. A chart review of bipolar and schizoaffective disorder patients who had received courses of at least two atypical agents (n = 33) in a community psychiatry system was conducted. No differences in rates of hospitalizations were found between individual atypical agents or between atypical agents as a class and conventional neuroleptics. However, a significant reduction in rates of emergency room visits was found with atypical agents compared to conventional neuroleptics, with a trend toward greater reduction with clozapine compared to other atypical antipsychotics. Larger prospective studies are needed to confirm these preliminary observations.

AB - No data are available comparing the relative efficacy of different atypical agents in patients with bipolar disorder. A chart review of bipolar and schizoaffective disorder patients who had received courses of at least two atypical agents (n = 33) in a community psychiatry system was conducted. No differences in rates of hospitalizations were found between individual atypical agents or between atypical agents as a class and conventional neuroleptics. However, a significant reduction in rates of emergency room visits was found with atypical agents compared to conventional neuroleptics, with a trend toward greater reduction with clozapine compared to other atypical antipsychotics. Larger prospective studies are needed to confirm these preliminary observations.

UR - http://www.scopus.com/inward/record.url?scp=0035104762&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035104762&partnerID=8YFLogxK

U2 - 10.1055/s-2001-15179

DO - 10.1055/s-2001-15179

M3 - Article

VL - 34

SP - 80

EP - 81

JO - Pharmacopsychiatry

JF - Pharmacopsychiatry

SN - 0176-3679

IS - 2

ER -